Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00800241

NIS-RTH-SYM-2008/1

Details and patient eligibility

About

The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.

Enrollment: 1,020 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Established persistent asthma
• Currently treated with Symbicort SMART for 3 months or longer

Exclusion criteria

• currently participating or have participated in a study with an investigational compound within the last 30 days
• current diagnosis of chronic obstructive pulmonary disease (COPD)
• smoked more than 10 pack-year